Cupid Shares Rise 2%, Extend Rally After Upbeat Q1 Update

Mumbai, July 8: Cupid Ltd share price extended rally on Wednesday, rising up to 2% in intraday trade as investors continued to cheer the sexual wellness products maker’s strong June-quarter business update and improved revenue outlook.

The stock has gained 19% in a week as the company raised its FY27 revenue guidance following a robust start to the financial year. Cupid has also emerged as one of the market’s biggest wealth creators, delivering a staggering nearly 940% return over the past year.

The sustained buying interest comes amid growing confidence that the company can maintain its earnings momentum, supported by healthy demand in both domestic and international markets. As of writing the stock was up 1.5% at Rs 224.4.

Strong Q1 update boosts sentiment

Investor optimism was triggered after Cupid announced that it expects to post record revenue of more than Rs 150 crore for the June quarter, reflecting strong execution across its core businesses.
Encouraged by the strong start to the year, the company also raised its FY27 revenue guidance to over Rs 660 crore, signalling confidence in demand visibility and order execution over the coming quarters.
The stock has rocketed nearly 940% over a year as investors bet on growth and momentum. Source: NSE

The improved outlook is backed by continued momentum in its sexual wellness business, expanding export opportunities and contributions from newer product segments.
The upbeat guidance has reinforced expectations of strong earnings growth, prompting investors to re-rate the stock.

Growth driven by diversified portfolio

Cupid manufactures a range of healthcare and sexual wellness products, including male and female condoms, water-based personal lubricants, diagnostic kits and in-vitro diagnostics (IVD) products.

The company exports its products to more than 100 countries and has built a strong presence in institutional markets through supplies to global agencies and governments. It has also been expanding its retail footprint in India while diversifying into newer healthcare categories.

The company’s ability to broaden its product portfolio while strengthening exports has helped it deliver consistent revenue growth over the past few years.

A standout multibagger

Cupid has significantly outperformed the broader market over the past year, with the stock rallying nearly tenfold as investors rewarded its improving financial performance and expanding growth prospects.

The latest rally has been driven by renewed buying after the company’s upbeat business update, with traders betting that higher revenues will translate into stronger profitability in the coming quarters.
The stock has also witnessed a sharp increase in trading volumes, reflecting heightened investor participation.

What lies ahead?

Despite the impressive run, analysts believe investors should closely monitor the company’s quarterly earnings and execution against its upgraded guidance.

The focus will be on whether Cupid can sustain its revenue momentum, maintain healthy operating margins and continue expanding its international business amid increasing competition in the healthcare and sexual wellness segments.

While the company’s strong growth outlook has supported the recent rally, the sharp appreciation in the share price has also pushed valuations higher. Going forward, further gains are likely to depend on the company’s ability to consistently deliver earnings growth and meet the ambitious targets it has set for FY27.

Source: https://www.nseindia.com/get-quote/equity/CUPID/Cupid-Limited